IPO Calendar
Lead Manager
- J P Morgan Chase (482)
- Goldman Sachs (458)
- Morgan Stanley (413)
- Bank of America Merrill Lynch (354)
- Citigroup (222)
- Jefferies (211)
- Credit Suisse (180)
- Barclays (150)
- Cowen and Company (145)
- Deutsche Bank (81)
- Piper Jaffray (70)
- Leerink Partners (69)
- Stifel (65)
- UBS Investment Bank (52)
- Evercore (51)
- RBC Capital (50)
- BMO Capital (49)
- Wells Fargo (45)
- William Blair (37)
- Raymond James (36)
More +
IPO - Pricing (6)
Piper Jaffray
| UnderWriters* | |||||||||||
| Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 3 | Kinnate BioPhar | Health-Care | 20 | 12 | GS | LRNK | PPRJ | 5.3% | 117.3% | ||
| Oct 16 | Aligos Therapeu | Health-Care | 15 | 10 | JPM | JEFF | PPRJ | 27.6% | -1% | ||
| Oct 8 | Aziyo Biologics | Health-Care | 17 | 2 | PPRJ | COWN | 70.5% | -14.7% | |||
| Oct 2 | Oncorus Inc. | Health-Care | 15 | 5 | JEFF | EVCR | PPRJ | 12.6% | 6.7% | ||
| Aug 19 | Harmony Bioscie | Health-Care | 37 | 24 | GS | JEFF | PPRJ | 2.4% | -2.5% | ||
| Jul 24 | Inozyme Pharma | Health-Care | 17 | 14 | BAML | COWN | PPRJ | 11.8% | 3.2% | ||
*
Lead manager or one of top three managers in an underwriting team.